A Blue-Green algae could ease menopause symptoms — a trial puts it to the test
NCT ID NCT07718399
First seen Jul 22, 2026 · Last updated Jul 23, 2026 · Updated 1 time
Summary
This trial tests whether taking 2 grams of spirulina daily for 8 weeks can improve metabolic health, body composition, sleep quality, and mood in mildly overweight postmenopausal women. Researchers will measure changes in blood sugar, cholesterol, weight, waist size, depression scores, and sleep quality. The goal is to see if this natural supplement can ease some of the common challenges of menopause.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- spirulina (a blue-green algae dietary supplement)
- What this could lead to
- If it works, spirulina could offer a natural option to help manage weight, blood sugar, sleep, and mood during menopause.
- What could go wrong
- This is a small, short-term trial (66 women, 8 weeks). Results may not apply broadly, and supplements are not regulated like drugs.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVERWEIGHT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Haliç University Faculty of Health Sciences
Istanbul, eyüpsultan, 34060, Turkey (Türkiye)
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Does injection location matter for a new Weight-Loss drug? a trial investigates
- A daily pill for obesity? zenagamtide faces its biggest test yet.
- Decades-Long study of 121,700 nurses aims to uncover hidden heart disease triggers
- New pill form of Weight-Loss drug could offer same benefits as capsules
- New oral drug aims to tackle obesity in chinese population
- Obesity drug UBT251 put to the test: will it clash with common meds?